Molecular Systems Biology (Mar 2023)
A methylation clock model of mild SARS‐CoV‐2 infection provides insight into immune dysregulation
- Weiguang Mao,
- Clare M Miller,
- Venugopalan D Nair,
- Yongchao Ge,
- Mary Anne S Amper,
- Antonio Cappuccio,
- Mary‐Catherine George,
- Carl W Goforth,
- Kristy Guevara,
- Nada Marjanovic,
- German Nudelman,
- Hanna Pincas,
- Irene Ramos,
- Rachel S G Sealfon,
- Alessandra Soares‐Schanoski,
- Sindhu Vangeti,
- Mital Vasoya,
- Dawn L Weir,
- Elena Zaslavsky,
- Biobank Team,
- Vanessa Barcessat,
- Kevin Tuballes,
- Diane Marie Del Valle,
- Kai Nie,
- Hui Xie,
- Grace Chung,
- Manishkumar Patel,
- Jocelyn Harris,
- Kimberly Argueta,
- Jacques Fehr,
- Barr Gruberg,
- Nicholas Zaki,
- Seunghee Kim‐Schulze,
- Sacha Gnjatic,
- Miriam Merad,
- Andrew G Letizia,
- Olga G Troyanskaya,
- Stuart C Sealfon,
- Maria Chikina
Affiliations
- Weiguang Mao
- Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh
- Clare M Miller
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Venugopalan D Nair
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Yongchao Ge
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Mary Anne S Amper
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Antonio Cappuccio
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Mary‐Catherine George
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Carl W Goforth
- Naval Medical Research Center
- Kristy Guevara
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Nada Marjanovic
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- German Nudelman
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Hanna Pincas
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Irene Ramos
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Rachel S G Sealfon
- Center for Computational Biology, Flatiron Institute, Simons Foundation
- Alessandra Soares‐Schanoski
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Sindhu Vangeti
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Mital Vasoya
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Dawn L Weir
- Naval Medical Research Center
- Elena Zaslavsky
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Biobank Team
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
- Vanessa Barcessat
- Kevin Tuballes
- Diane Marie Del Valle
- Kai Nie
- Hui Xie
- Grace Chung
- Manishkumar Patel
- Jocelyn Harris
- Kimberly Argueta
- Jacques Fehr
- Barr Gruberg
- Nicholas Zaki
- Seunghee Kim‐Schulze
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
- Sacha Gnjatic
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
- Miriam Merad
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
- Andrew G Letizia
- Naval Medical Research Center
- Olga G Troyanskaya
- Center for Computational Biology, Flatiron Institute, Simons Foundation
- Stuart C Sealfon
- Department of Neurology, Icahn School of Medicine at Mount Sinai
- Maria Chikina
- Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh
- DOI
- https://doi.org/10.15252/msb.202211361
- Journal volume & issue
-
Vol. 19,
no. 5
pp. 1 – 16
Abstract
Abstract DNA methylation comprises a cumulative record of lifetime exposures superimposed on genetically determined markers. Little is known about methylation dynamics in humans following an acute perturbation, such as infection. We characterized the temporal trajectory of blood epigenetic remodeling in 133 participants in a prospective study of young adults before, during, and after asymptomatic and mildly symptomatic SARS‐CoV‐2 infection. The differential methylation caused by asymptomatic or mildly symptomatic infections was indistinguishable. While differential gene expression largely returned to baseline levels after the virus became undetectable, some differentially methylated sites persisted for months of follow‐up, with a pattern resembling autoimmune or inflammatory disease. We leveraged these responses to construct methylation‐based machine learning models that distinguished samples from pre‐, during‐, and postinfection time periods, and quantitatively predicted the time since infection. The clinical trajectory in the young adults and in a diverse cohort with more severe outcomes was predicted by the similarity of methylation before or early after SARS‐CoV‐2 infection to the model‐defined postinfection state. Unlike the phenomenon of trained immunity, the postacute SARS‐CoV‐2 epigenetic landscape we identify is antiprotective.
Keywords